Indian bulk drug market in 2006 was about USD 3.29 billion, witnessing a growth of 19% over 2005 at a CAGR of 18.81% in the last six years. India ranks 4th in terms of volume, among the top 15 drug manufacturing countries worldwide. Indian companies have the distinction of developing cost-effective technologies for manufacturing bulk drugs and intermediates, conforming to global standards. India has over 80 US FDA approved plants, the second highest in the world.
Nearly 70% of the bulk drugs, manufactured are exported to more than 50 countries. Contract manufacturing in India in 2006 was USD 658.6 million, registering a growth of 48% over previous year. Indian companies have filed 408 DMF's during 2006 out of a total 704. By 2010, Indian bulk drugs market is projected to grow to about USD 6.54 billion and contract manufacturing to USD 1.5 billion.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment